glp-1 news today november 2025 Who Gets the Shot? Access by State New oral GLP-1 drug delivers
Description
For example, in clinical trials of Wegovy, hair loss was reported in 2.5% of Wegovy-treated adult patients vs 1.0% of placebo-treated adult patients
, Gustafsson, T
Abbas T, Faivre E, Hlscher C
41 Gastrointestinal symptoms, however, tend to be transient and less severe with proper dose titration
Note: DTC = Direct-to-consumer
Segmental Analysis GLP-1 Receptor Agonist Market Analysis by Route of Administration Market Overview: Parenteral administration is expected to hold 80% of the GLP-1 receptor agonist market by 2026
